Trumponomics Explained
October 25, 2016
Steve Keen talks to us about Trump, China, free trade and globalization
1 min read
September 2016
Welcome to the September issue. Experts give their view on Mylan and strategies for drug pricing, the importance of public relations, and the importance of placebos in lyophilization. Our cover feature looks to the upcoming US elections and asks what the potential impact could be on pharmaceutical pricing. In Nextgen, find out how hair follicles and nanoparticles can aid transdermal drug delivery. In Business, we ask if biologics litigations are about to increase. We also Sit Down With Akm Khairuzzaman from the FDA to discuss 3D printing.
Discovery & Development
Facilities & Equipment
Technology & Manufacturing
Business & Trends
Formulation
The Science of Insolubility
September 26, 2016
Experts come together to discuss the chemistry of solubility – and the solutions of the future
1 min read
All Aboard for Continuous Coating
September 21, 2016
The industry is searching for greater manufacturing efficiencies; continuous processing could be the solution. But robust formulation and coating expertise are required to get the best results.
1 min read
The Great Debate: Stainless Steel Versus Single Use
September 21, 2016
Initially viewed with caution by the bioprocessing industry, single-use systems have become mainstream technology. Will single-use eventually win out over traditional stainless steel, or will hybrid systems offer the best of both worlds?
1 min read
When Single Use Meets Continuous Bioprocessing
September 21, 2016
Single-use technology has made its mark on traditional biopharma manufacturing – now, it promises to help pave the way for continuous bioprocessing.
1 min read
Manufacture
Regulation & Standards
Business & Trends
Cell & Gene
Formulation
Facilities & Equipment
Technology & Manufacturing
Regulating a 3D-Printed Future
September 21, 2016
Sitting Down With… Akm Khairuzzaman, Acting Branch Chief, Branch I, Division I, Office of Process & Facilities, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA
1 min read
Surveying the Biologic Patent Battleground
September 21, 2016
Biopharmaceuticals have certainly made their mark on the pharma industry. With an approaching patent cliff, are we about to see a rise in litigation challenges?
1 min read
Follicular Drug Delivery: a Root to Success
September 21, 2016
Delivering drugs through the skin without the use of needles has proven a significant challenge for the scientific community. But what about exploiting hair follicles?
1 min read
The Science of Sugar: Lessons Learned with Pauline Rudd
September 21, 2016
Pauline Rudd’s passion for glycans started early – as a teenager she experimented with extracting sugars from natural products in her kitchen. Today, she is a principal investigator at NIBRT – Ireland’s National Institute for Bioprocessing Research and Training. Here, she reflects on her early interest, and the complex but crucial role of glycobiology in biosimilar development.
1 min read
Bioprocess Knowledge Is Power
September 21, 2016
Outsourcing can be an effective way to access in-depth bioprocessing expertise, but leaning on external resources can restrict internal learning. Is there a way to get the best of both worlds?
1 min read
The Great American Debate
September 21, 2016
It’s Trump versus Clinton in the US elections race. Who will become the 45th President of the United States of America? And how will the pharma industry be affected?
1 min read
mAbs: Hybrid Style
September 21, 2016
Batch or continuous processing? That is the question. With monoclonal antibodies, there are benefits in combining the best of both worlds.
1 min read
Discovery & Development
Formulation
Facilities & Equipment
Technology & Manufacturing
Small Molecules
The Placebo Effect
September 21, 2016
A warning about using lyophilization placebos that are inappropriate or incongruous with your actual product.
1 min read
Who Are You?
September 21, 2016
You may know what your company does, but does the wider world know? Costs of failing to communicate can range from collaborations to investment.
1 min read
Imprudent Pricing
September 21, 2016
The Mylan “episode” is a prime example of what happens when a company makes a pricing decision without full consideration of the bigger picture.
1 min read
And a New Era at GSK
September 21, 2016
Emma Walmsley is selected to succeed Andrew Witty as GlaxoSmithKline’s new CEO
1 min read
End of an Era at EFPIA
September 21, 2016
Richard Bergström has resigned – who will replace him?
1 min read
A Question of Access
September 21, 2016
A report from the United Nations offers recommendations to increase access to medicines, but not everyone is on board
1 min read
CPhI in Numbers
September 21, 2016
CPhI returns to Spain for the second year in a row, but it is the show’s first appearance in the City of Counts - Barcelona
1 min read
Can Slow and Steady Win the Cancer Race?
September 21, 2016
Researchers argue it’s time to consider cancer as a chronic disease. And that means more frequent treatment at lower doses
1 min read
Breaking the Habit
September 21, 2016
Can a cancer drug be repurposed to cure cocaine addiction?
1 min read
Walking the Biosimilar Guideline
September 21, 2016
Not all successful biosimilar applications in Europe follow regulatory guidelines to the letter
1 min read
